Dr. Wadwa is the medical director of the pediatric clinic and director of the telemedicine program at the Barbara Davis Center. The goal of the telemedicine program is to deliver type 1 diabetes care to pediatric patients living at a distance from the center that makes regular follow up difficult. Over the coming years, the BDC telemedicine program plans to analyze telemedicine data to quantify long term benefits in glycemic control and rates of microvascular complications for patients requiring the use of telemedicine as a part of their diabetes care. Dr. Wadwa’s primary research focus is on the development of the artificial pancreas. He is involved in several clinical research studies with the goal of advancing artificial pancreas technology. Dr. Wadwa is also engaged in clinical trials of new therapeutic agents. The next decade will bring significant advances in delivery of diabetes care as well as in medications and devices used to care for patients with type 1 diabetes. Clinical trials in this area are crucial to bring the most advanced medical care to patients with type 1 diabetes. Dr. Wadwa is excited to be a part of these rapidly advancing areas of diabetes care and strives to improve the lives of people living with diabetes.